XBIOTECH INC. Common Stock, Value, Issued
XBIOTECH INC. (XBIT) had Common Stock, Value, Issued of $277.07 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-13
- 2026-06-30: Common Stock, Value, Issued $277.07M.
- 2026-03-31: Common Stock, Value, Issued $276.90M.
- 2025-12-31: Common Stock, Value, Issued $276.73M.
- 2025-09-30: Common Stock, Value, Issued $276.56M.
| Period end | Common Stock, Value, Issued |
|---|---|
| 2026-06-30 | $277.07M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $276.90M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $276.73M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $276.56M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $276.54M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $276.43M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $273.11M 10-K · filed 2026-03-13 |
| 2024-09-30 | $272.44M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $272.01M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $271.59M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $271.15M 10-K · filed 2025-03-18 |
| 2023-09-30 | $269.89M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $268.93M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $268.03M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $267.32M 10-K · filed 2024-03-15 |
| 2022-09-30 | $266.29M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $265.16M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $263.71M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $262.26M 10-K · filed 2023-03-15 |
| 2021-09-30 | $260.88M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $256.78M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $255.51M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $249.81M 10-K · filed 2022-03-15 |
| 2020-09-30 | $251.78M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $246.40M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $242.94M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $324.81M 10-K · filed 2021-03-16 |
| 2019-09-30 | $320.13M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $319.05M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $280.66M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $279.35M 10-K · filed 2020-03-16 |
| 2018-09-30 | $278.88M 10-Q · filed 2018-10-31 |
| 2018-06-30 | $278.44M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $277.80M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $277.49M 10-K/A · filed 2019-03-15 |
| 2017-09-30 | $277.08M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $276.59M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $276.08M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $242.42M 10-K · filed 2018-03-16 |
| 2016-09-30 | $238.81M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $237.52M 10-Q · filed 2016-08-12 |
| 2016-03-31 | $235.75M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $233.90M 10-K · filed 2017-03-16 |
| 2015-09-30 | $232.85M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $231.94M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $156.39M 10-Q · filed 2015-06-18 |
| 2014-12-31 | $152.35M 10-K · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |